Although CA 19-9 has been widely recognized as a marker associated with metastatic disease in pancreatic cancer,13 the prognostic role of CEA in PDAC, particularly regarding its association with metastatic disease versus local progression, is less well established. This evidence concerns the gene CEACAM5 and metastatic neoplasm.